$EXOZ
eXoZymes Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateeXoZymes Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is EXOZ up today? It is at $6.43 (+3.96%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EXOZ spikes, and full due diligence on EXOZ — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $EXOZ 1 time in the last 30 days. Create a free account to track $EXOZ, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on EXOZ from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EXOZ today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Heltzen Michael Officer | Bought (open market) | +505 | added 3.6% | 15K | $4K at $7.35 | Aug 26, 26 |
Heltzen Michael Officer | Bought (open market) | +350 | added 2.5% | 14K | $3K at $7.50 | Aug 25, 26 |
Korman Tyler Paz Officer | Other | 33K 0.4% of company | added 4.5% | 763K | n/a | Aug 19, 26 |
Perriman Damien Alan Officer | Other | 20K 0.2% of company | added 100% | 28K | n/a | Aug 19, 26 |
Heltzen Michael Officer | Acquired (grant/award) | +9K 0.10% of company | added 100% | 14K | $57K at $6.40 | Aug 19, 26 |
Korman Tyler Paz Officer | Sold (automatic/other) | -750 | sold 0.1% | 729K | $8K at $10.53 | Apr 9, 26 |
Korman Tyler Paz Officer | Sold (automatic/other) | -750 | sold 0.1% | 730K | $8K at $10.04 | Apr 8, 26 |
Korman Tyler Paz Officer | Acquired (grant/award) | +5K 0.06% of company | added 0.7% | 731K | $45K at $8.44 | Apr 1, 26 |
Nawaz Fouad Officer | Acquired (grant/award) | +6K 0.06% of company | added 100% | 9K | $51K at $8.44 | Apr 1, 26 |
Opgenorth Paul Hideo Officer | Acquired (grant/award) | +4K 0.04% of company | added 0.6% | 645K | $34K at $8.44 | Apr 1, 26 |
Perriman Damien Alan Officer | Acquired (grant/award) | +9K 0.10% of company | n/a | n/a | $75K at $8.44 | Apr 1, 26 |
Perriman Damien Alan Officer | Acquired (grant/award) | +63K 0.7% of company | n/a | 63K | n/a | Apr 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on EXOZ from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EXOZ today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
EXOZ last traded at $6.43, up 3.96% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
eXoZymes Inc. Common Stock (EXOZ) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The EXOZ Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EXOZ 1 time in the last 30 days.
EXOZ (eXoZymes Inc. Common Stock) trades on XNAS, with a market cap of about $60M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EXOZ for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$EXOZ discussion
Sign in to ask a question or join the discussion.